NG-350A IV administration clinical trials

NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer

This study is testing a new drug called NG-350A, given into a vein, alongside standard treatment (chemotherapy and radiotherapy) for locally advanced bowel cancer in the back passage (rectum). It aims to see how safe and effective this combination is for adults.